Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
ClinicalTrials.gov study NCT00487448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00916227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02649764. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 in Patients Treated for Higher-risk Myelodysplastic Syndromes Experiencing Hypomethylating Agent Failure.
ClinicalTrials.gov study NCT04109690. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.
ClinicalTrials.gov study NCT03107273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01809392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02078609. IPD Sharing: NO. Countries: 7. Publications: 0.
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00087204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00402558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00459524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04997811. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02093429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
ClinicalTrials.gov study NCT06073860. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04278768. IPD Sharing: NO. Countries: 8. Publications: 0.
5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01652781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
ClinicalTrials.gov study NCT06510868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00002805. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
ClinicalTrials.gov study NCT05181592. IPD Sharing: NO. Countries: 4. Publications: 0.
5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01041443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Velcade in Myelodysplastic Syndrome - Pilot Study
ClinicalTrials.gov study NCT00440076. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.